• 1. Synthesis of donor-substituted meso-phenyl and meso-ethynylphenyl BODIPYs with broad absorption
  Katja Gr?f,Thomas K?rzd?rfer,Stephan Kümmel,Mukundan Thelakkat New J. Chem. 2013 37 1417

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoyl derivatives

Chemical Profile of 4-(1,3-dioxolan-2-yl)benzaldehyde (CAS No. 40681-88-7)

4-(1,3-dioxolan-2-yl)benzaldehyde, identified by its Chemical Abstracts Service (CAS) number 40681-88-7, is a versatile organic compound that has garnered significant attention in the field of pharmaceutical chemistry and material science. This compound belongs to the benzaldehyde derivatives family, characterized by the presence of a benzene ring substituted with an aldehyde group and a 1,3-dioxolan moiety at the para position. The unique structural features of this molecule make it a valuable intermediate in synthetic chemistry and a potential candidate for various biological applications.

The 1,3-dioxolan ring, also known as a tetrahydropyranone scaffold, is a prominent structural motif in natural products and pharmaceuticals. Its presence in 4-(1,3-dioxolan-2-yl)benzaldehyde imparts specific chemical and biological properties, including enhanced stability and reactivity. This dioxolan group is particularly interesting because it can participate in various chemical transformations, such as oxidation-reduction reactions and nucleophilic additions, making it a useful building block for drug discovery and molecular design.

Benzaldehyde derivatives have long been studied for their pharmacological properties. The aldehyde functional group in 4-(1,3-dioxolan-2-yl)benzaldehyde allows for further functionalization through condensation reactions with amino compounds, leading to Schiff bases or heterocyclic compounds. These derivatives have shown promise in various therapeutic areas, including anti-inflammatory, antimicrobial, and anticancer applications. Recent studies have highlighted the role of benzaldehyde-based compounds in modulating enzyme activity and interacting with biological targets.

One of the most compelling aspects of 4-(1,3-dioxolan-2-yl)benzaldehyde is its potential as a precursor in the synthesis of more complex molecules. The dioxolan ring can be selectively modified or removed under specific conditions, allowing chemists to tailor the compound's properties for targeted applications. For instance, researchers have explored its use in the development of chiral auxiliaries and catalysts due to the stereoelectronic effects induced by the dioxolan moiety.

In the realm of medicinal chemistry, 4-(1,3-dioxolan-2-yl)benzaldehyde has been investigated for its ability to interact with biological systems. The benzaldehyde moiety can form hydrogen bonds with nucleophilic residues in proteins and enzymes, while the dioxolan ring provides additional conformational flexibility. This dual functionality has been exploited in the design of small-molecule inhibitors that target specific disease-related pathways. For example, derivatives of this compound have been studied for their potential to inhibit kinases and proteases involved in cancer progression.

The synthesis of 4-(1,3-dioxolan-2-yl)benzaldehyde typically involves multi-step organic reactions starting from readily available precursors. Common synthetic routes include cyclization reactions followed by functional group transformations to introduce the aldehyde group and the dioxolan moiety. Advances in catalytic methods have enabled more efficient and sustainable synthesis routes, reducing waste generation and improving yield. These advancements are crucial for scaling up production while maintaining environmental responsibility.

Recent research has also explored the application of 4-(1,3-dioxolan-2-yl)benzaldehyde in material science. The compound's ability to form coordination complexes with metal ions has been utilized in the development of metal-organic frameworks (MOFs) and supramolecular assemblies. These materials exhibit unique properties such as high surface area and tunable porosity, making them suitable for applications in gas storage, separation technologies, and catalysis.

The pharmacokinetic properties of 4-(1,3-dioxolan-2-yl)benzaldehyde are another area of interest. Studies have shown that modifications to the dioxolan ring can influence metabolic stability and bioavailability. By optimizing these structural features, researchers aim to develop derivatives with improved pharmacokinetic profiles suitable for clinical use. This approach aligns with current trends in drug development towards rational molecular design based on structure-activity relationships.

In conclusion,4-(1,3-dioxolan-2-yl)benzaldehyde (CAS No. 40681-88-7) represents a fascinating compound with broad utility across multiple scientific disciplines. Its unique structural features offer opportunities for innovation in pharmaceuticals, materials science, and synthetic chemistry. As research continues to uncover new applications and synthetic strategies,this molecule is poised to play an increasingly important role in advancing scientific knowledge and technological development.

• 103890-70-6(Benzaldehyde,2-(diethoxymethyl)-)
• 936-51-6(2-PHENYL-1,3-DIOXOLANE)
• 81172-89-6(Terephthaldehyde monodiethylacetal)
• 5660-64-0(1,3-Dioxolane,2-(3-methylphenyl)-(9CI))
• 2403-51-2(1,3-Dioxolane,2-(4-methylphenyl)-)
• 150990-60-6(3-(Diethoxymethyl)benzaldehyde)
• 66822-18-2(1,3-Dioxolan-2-yl, 2-phenyl-)
• 68348-23-2(3-(1,3-dioxolan-2-yl)benzaldehyde)
• 400744-10-7(4'-(1,3-Dioxolan-2-yl)biphenyl-3-carboxylic acid)
• 400750-26-7(3'-(1,3-Dioxolan-2-yl)biphenyl-3-carboxylic acid)